AI Presentations for Pharma: Sales, MSL and Medcomms (2026)

AI presentations for pharma work when you treat the AI as a drafting tool for internal and pre-review content, not as a shortcut to field materials. Anything a rep shows a healthcare professional still goes through MLR (medical, legal, regulatory) review and must be consistent with the label. The high-value uses are internal: rep training on disease state and competitor landscape, MSL congress debriefs built from public abstracts, launch-readiness decks, and first drafts that agencies submit into MLR. In 2Slides, a 15-slide editable congress debrief costs 150 credits, about $0.38.

Key takeaways

• Promotional slides need MLR or PRC approval before field use; AI cuts drafting time, not review steps. A 15-slide internal deck in Fast PPT is 150 credits (about $0.38 on the $5 pack).
• MSL scientific exchange is non-promotional and kept separate from sales. Build separate decks, separate prompts, and separate source sets for each function.
• Feed only public or approved, non-confidential text: published abstracts, the approved label, public competitor PIs. Never unpublished clinical data or patient data without formal approval.
• One English master can become drafts in 20+ languages for affiliates, and each still goes through local review. Ten language drafts of a 15-slide deck cost 1,500 credits, about $3.75.
• 2Slides makes no GxP, 21 CFR Part 11, HIPAA, or SOC 2 claim. It is not a validated system and not a substitute for your MLR platform.

The rules that shape every pharma deck

The ground rules decide which use cases are safe.

Promotion is regulated. In the US, FDA's Office of Prescription Drug Promotion (OPDP) oversees prescription drug promotion, including sales representative presentations and speaker programs. Promotional claims must be truthful, balanced between efficacy and risk, and consistent with the approved labeling. That is why every promotional asset in your company passes through MLR or PRC review, usually tracked in a system like Veeva Vault PromoMats, and gets a job code before anyone uses it.

HCP interactions follow industry codes. The PhRMA Code on Interactions with Health Care Professionals sets expectations in the US for speaker programs, educational items, and the purpose of interactions. In Europe, the EFPIA Code and its national implementations play the same role, with local codes often stricter than the umbrella.

Medical and commercial are separated. MSLs conduct non-promotional scientific exchange, often responding to unsolicited questions, and their materials are reviewed through a medical pathway, not a promotional one. A slide that is acceptable in an MSL's reactive deck can be off-label promotion in a rep's hands.

What this means for AI: you do not want a model writing persuasive field copy from loose prompts. You do want one turning public abstracts into a clean internal summary, or approved messaging into a first draft for MLR. Every use case below sits on that second side.

What AI is good for in pharma, by team

Missing on purpose: "a detail aid reps show doctors tomorrow." That never skips review.

Use case 1: Internal rep training decks

New-hire training and POA (plan of action) meetings eat enablement time. A disease-state module (pathophysiology, epidemiology, diagnosis, guidelines, patient journey) comes entirely from public sources and never leaves the building, which makes it ideal AI work.

For the general structure of enablement content, see how to create a sales enablement deck with AI. For pharma, add three rules:

1. Label as internal. Every training slide carries "For internal training only. Not for promotional use." in the footer.
2. Cite everything. Ask for a reference on every clinical claim, then check each one. AI models invent plausible citations; the AI presentation hallucinations fact-checking guide walks through a checking routine.
3. Keep the competitor landscape public. Competitor PIs, approved indications, public trial readouts. No rumor, no field intel with HCP names.

Example prompt for Fast PPT:

Fast PPT fills a template with native, editable text boxes, so your training lead can fix wording in PowerPoint and add the company's approved references. Pick a clean, low-ornament template.

Figure 1: The Fast PPT page, which produces editable PPTX decks at 10 credits per page.

Use case 2: MSL congress debriefs and publication summaries

After ASCO, ESMO, ADA, or EASD, field medical teams need a fast, accurate summary of what was presented: your data, competitor data, and what KOLs said in public sessions. The MSL slide deck for an internal congress debrief is one of the cleanest AI use cases in medical affairs because the source is public abstracts and the audience is internal.

Worked example: 30 public abstracts to a 15-slide debrief

Source material. An MSL lead exports 30 public abstracts from a major oncology congress in one indication: 6 from your company, 14 from competitors, 10 from investigator-initiated studies. They paste titles, authors, and abstract text into one document, about 9,000 words, and add a one-paragraph brief. Nothing unpublished goes in: no data-on-file, no embargoed late-breakers before release, no internal medical strategy.

The prompt.

What you get. In Fast PPT, an editable 15-slide PPTX in about a minute: a summary slide, grouped competitor slides with endpoint bullets, and a reference list. Cost: 15 pages x 10 credits = 150 credits, about $0.38 on the $5 pack, well inside the 500 free credits for a new account.

If the debrief is also going to the wider medical org as a short video for people who missed the internal call, run the same document through Create Slides from File and add narration:

Designed slides are images: they look polished and export to MP4, PDF, and PNG, but you cannot edit the text in PowerPoint. For decks a medical director will mark up, stay on Fast PPT.

What you still do by hand. This is the part that matters:

• Check every number against the source abstract. Hazard ratios, confidence intervals, and medians are where models slip. Read the hallucination guide before your first run.
• Remove any implied cross-trial comparison. AI likes to rank things side by side.
• Rewrite "implications" slides in your medical team's voice, framed as questions.
• Route through your medical review process and store the final version in your system of record, not in 2Slides.

Budget about 90 minutes for checking and edits, versus the full day a hand-built debrief typically takes.

The same pattern works for publication summaries: one peer-reviewed paper in, a 6 to 8 slide journal-club style summary out.

Use case 3: Medical information and MLR-submission drafts

Medical information teams answer unsolicited requests with approved standard response letters, and sometimes a slide version is needed for an MSL's reactive deck. AI converts the approved document into a draft slide set in minutes; the draft then goes into MLR like any other asset.

Tips for drafts that review faster:

• No new claims. "Use only the wording in the source. Do not add claims, adjectives, or comparisons."
• Safety placeholders. Ask for ISI and boxed warning placeholder slides, then insert the approved text yourself.
• Keep references. Preserve the source's reference numbering so reviewers can annotate against the reference pack.

The output is a submission draft, not a final asset. Its value is a clean first version for reviewers.

Use case 4: Brand plans, launch readiness, and cycle meetings

Brand plan reviews, launch-readiness trackers, POA and cycle-meeting decks are internal, so the constraint is confidentiality, not promotion: strategy, forecasts, and pricing are sensitive.

Two rules:

1. Check whether your company permits the content in a third-party AI tool at all. Many pharma companies restrict this to enterprise tools inside their own tenant. Read are AI presentations safe for confidential data and the GDPR and HIPAA AI presentation tools guide before uploading anything.
2. If permitted, strip forecasts and account-level data, and feed the structure and public context. You can add the sensitive numbers back in PowerPoint.

Use Fast PPT here, because brand leads edit decks constantly.

Use case 5: Localization drafts for affiliates

Global teams create a master, and 20 affiliates each need a local-language version. AI can produce a first-pass draft of an approved master for every market at once, so local teams start from a structured deck instead of a blank one.

2Slides generates in 20+ languages; you set the output language per deck (see creating slides in 19+ languages with AI). The non-negotiable step: every localized draft still goes to local medical review and local MLR, because the local label, local indication, and local code (national EFPIA implementations differ) may require changes that no translation captures. A 15-slide master in 10 languages via Fast PPT is 1,500 credits, about $3.75.

Use case 6: Medcomms agencies producing first drafts

Medcomms agencies produce advisory board pre-reads, speaker training, client presentations, and MLR submission drafts. The first draft is commodity work; the medical writing judgment is the product. AI speeds the commodity part.

For agencies running many variants, such as one disease-state deck adapted for five audiences in eight languages, the 2Slides API is a better fit than the web app. Each call returns a jobId, which you log alongside the source version, the brief, and the reviewer, giving you a version trail to hand to the client.

Figure 2: The 2Slides API reference. Keys stay server-side and use your account's credits.

Automate it with the API

A minimal request for one language draft of an approved master:

Poll GET /api/v1/jobs/{id} every 5 to 10 seconds until it returns a downloadUrl for the PPTX. Store the file with the job ID, the source version, and the language in your own audit table, and mark it pending_review. The rate limit is 6 generation requests per minute per key, so a 40-variant batch takes about 7 minutes to submit.

The full pattern, including a Python review queue that never publishes without an approval row, is in patient education slides automation with a healthcare API. The same operations are available as an MCP server and Agent Skills.

Data rules: what never goes into a third-party AI tool

Share this with every rep, MSL, and agency writer who uses AI:

• No patient data. No case details, no adverse event reports with identifiers, no patient support program data.
• No unpublished clinical data without formal approval: no data-on-file, no topline results before disclosure, no embargoed abstracts before the embargo lifts.
• No HCP-level data. No call notes, no prescribing data, no KOL mapping with names.
• No unapproved claims as input. Starting from unapproved messaging produces unapproved output.
• No direct-to-field use. No AI-drafted slide reaches an HCP without your standard review and job code.

2Slides makes no GxP, 21 CFR Part 11, HIPAA, or SOC 2 claim. It is not a validated system, it does not provide electronic signatures or a regulated audit trail, and it does not replace Veeva PromoMats or your MLR platform. Your system of record stays your system of record.

How 2Slides compares with other AI slide tools for pharma

If your company only permits AI inside its own Microsoft tenant, Copilot is the honest answer for confidential content. 2Slides fits public-source and pre-approved content, agency variant production, and multilingual or narrated output. For clinical and hospital use cases, see the healthcare and medical slides guide.

Where 2Slides is not the right tool

• Final promotional assets. Detail aids, leave-behinds, and speaker decks are built and approved in your MLR workflow. Use 2Slides only for drafts that enter that workflow.
• Validated or GxP contexts. Anything that must live in a validated system, such as regulatory submissions or controlled training records, does not belong here.
• Confidential strategy without approval. If your company has not cleared the tool for internal data, keep to public sources.
• Pixel-level brand compliance. Fast PPT uses its own templates, not your corporate master.
• Editable designed slides. Workspace-flow slides are images. Great for videos and read-only pre-reads, not for decks people will edit.

FAQ

Can pharma sales reps use AI to make presentations for doctors?

Reps can use AI to draft internal training and prep material, but anything shown to an HCP must be an MLR-approved asset with a job code. AI-drafted slides do not go directly into the field.

Is it OK for MSLs to use AI for slide decks?

Yes, for internal work built from public sources, such as congress debriefs and publication summaries, provided your medical team allows the tool. Materials used in scientific exchange still go through your medical review process.

Does AI-generated content need MLR review?

Any promotional or HCP-facing content needs review, regardless of who or what drafted it. AI changes the drafting step, not the review requirement.

Can I upload clinical trial data to an AI presentation tool?

Only published data, unless your company has formally approved the tool for confidential data. Never upload unpublished results, data-on-file, or anything containing patient information.

Is 2Slides GxP or 21 CFR Part 11 compliant?

No. 2Slides makes no GxP, Part 11, HIPAA, or SOC 2 claim and is not a validated system. Use it for drafts and internal content, and keep final assets in your validated systems.

How much does an AI congress debrief deck cost?

A 15-slide editable debrief in Fast PPT costs 150 credits, about $0.38. A designed and narrated video version costs about 4,660 credits. New accounts get 500 free credits.

Start with an internal training deck or a congress debrief built from public abstracts in Fast PPT, and keep MLR exactly where it is.